Xvivo Perfusion AB (publ) (XVIPF)
USD 41.1
(0.0%)
USD 41.1
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 21.16 Million SEK | 375.17% |
| 2022 | 4.45 Million SEK | 192.71% |
| 2021 | 1.52 Million SEK | -53.68% |
| 2020 | 3.28 Million SEK | 52.55% |
| 2019 | 2.15 Million SEK | 0.0% |
| 2018 | - SEK | 0.0% |
| 2017 | - SEK | 0.0% |
| 2016 | - SEK | 0.0% |
| 2015 | - SEK | 0.0% |
| 2014 | - SEK | 0.0% |
| 2013 | - SEK | 0.0% |
| 2012 | - SEK | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 19.91 Million SEK | 0.0% |
| 2024 Q2 | - SEK | 0.0% |
| 2024 Q3 | - SEK | 0.0% |
| 2023 FY | 21.16 Million SEK | 375.17% |
| 2023 Q4 | 21.16 Million SEK | 31.73% |
| 2023 Q1 | 159.68 Million SEK | 3484.38% |
| 2023 Q2 | 170.73 Million SEK | 6.92% |
| 2023 Q3 | 16.07 Million SEK | -90.59% |
| 2022 Q4 | 4.45 Million SEK | 221.2% |
| 2022 Q3 | 1.38 Million SEK | -25.99% |
| 2022 Q2 | 1.87 Million SEK | 14.83% |
| 2022 Q1 | 1.63 Million SEK | 7.23% |
| 2022 FY | 4.45 Million SEK | 192.71% |
| 2021 Q4 | 1.52 Million SEK | 104.02% |
| 2021 Q1 | 2.16 Million SEK | -34.27% |
| 2021 Q2 | 1.64 Million SEK | -23.8% |
| 2021 Q3 | 746 Thousand SEK | -54.68% |
| 2021 FY | 1.52 Million SEK | -53.68% |
| 2020 Q1 | 4.04 Million SEK | 87.65% |
| 2020 Q2 | 2.58 Million SEK | -36.05% |
| 2020 Q3 | 1.56 Million SEK | -39.57% |
| 2020 Q4 | 3.28 Million SEK | 110.37% |
| 2020 FY | 3.28 Million SEK | 52.55% |
| 2019 Q1 | 4.57 Million SEK | 0.0% |
| 2019 FY | 2.15 Million SEK | 0.0% |
| 2019 Q3 | 3.01 Million SEK | -23.39% |
| 2019 Q2 | 3.92 Million SEK | -14.16% |
| 2019 Q4 | 2.15 Million SEK | -28.44% |
| 2018 FY | - SEK | 0.0% |
| 2018 Q2 | 3.29 Million SEK | -0.09% |
| 2018 Q3 | 3.29 Million SEK | -0.12% |
| 2018 Q4 | - SEK | -100.0% |
| 2018 Q1 | 3.3 Million SEK | 0.0% |
| 2017 Q2 | 3.16 Million SEK | 0.99% |
| 2017 Q1 | 3.13 Million SEK | 0.0% |
| 2017 Q3 | 3.19 Million SEK | 1.01% |
| 2017 Q4 | - SEK | -100.0% |
| 2017 FY | - SEK | 0.0% |
| 2016 Q2 | - SEK | 0.0% |
| 2016 Q1 | - SEK | 0.0% |
| 2016 FY | - SEK | 0.0% |
| 2016 Q4 | - SEK | 0.0% |
| 2016 Q3 | - SEK | 0.0% |
| 2015 Q1 | - SEK | 0.0% |
| 2015 FY | - SEK | 0.0% |
| 2015 Q4 | - SEK | 0.0% |
| 2015 Q3 | - SEK | 0.0% |
| 2015 Q2 | - SEK | 0.0% |
| 2014 Q2 | - SEK | 0.0% |
| 2014 Q1 | - SEK | 0.0% |
| 2014 FY | - SEK | 0.0% |
| 2014 Q4 | - SEK | 0.0% |
| 2014 Q3 | - SEK | 0.0% |
| 2013 Q2 | - SEK | 0.0% |
| 2013 Q4 | - SEK | 0.0% |
| 2013 Q1 | - SEK | 0.0% |
| 2013 FY | - SEK | 0.0% |
| 2013 Q3 | - SEK | 0.0% |
| 2012 FY | - SEK | 0.0% |
| 2012 Q4 | - SEK | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| AVITA Medical, Inc. | 449.48 Thousand USD | -4609.633% |
| Manhattan Scientifics, Inc. | - USD | -Infinity% |
| Össur hf. | 311.8 Million USD | 93.211% |
| QHSLab, Inc. | - USD | -Infinity% |
| Wellstar International, Inc. | 18.86 Million USD | -12.233% |
| Össur hf. | 311.8 Million USD | 93.211% |
| CVR Medical Corp. | - USD | -Infinity% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| Escalon Medical Corp. | 279.4 Thousand USD | -7476.484% |
| Aurora Spine Corporation | 1.59 Million USD | -1229.867% |
| BrainsWay Ltd. | 239 Thousand USD | -8757.322% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| BioElectronics Corporation | 12.52 Million USD | -68.952% |
| Hamilton Thorne Ltd. | 16.7 Million USD | -26.716% |
| Vivos Inc. | - USD | -Infinity% |
| Kelyniam Global, Inc. | 217.61 Thousand USD | -9627.909% |
| REMSleep Holdings, Inc. | 43.67 Thousand USD | -48368.266% |
| Zecotek Photonics Inc. | - USD | -Infinity% |
| Avitar, Inc. | 3.89 Million USD | -443.289% |
| Nanomix Corporation | 10.11 Million USD | -109.356% |
| EKF Diagnostics Holdings plc | 618 Thousand USD | -3325.405% |
| Theraclion SA | 1.95 Million EUR | -985.18% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Positron Corporation | - USD | -Infinity% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 150 Thousand USD | -14012.667% |
| Lombard Medical, Inc. | 28.02 Million USD | 24.464% |
| ALR Technologies Inc. | - USD | -Infinity% |
| Stratec SE | 89.25 Million USD | 76.283% |
| Vycor Medical, Inc. | 243.28 Thousand USD | -8601.246% |
| Heart Tronics, Inc. | - USD | -Infinity% |
| MicroPort Scientific Corporation | 814.21 Million USD | 97.4% |
| VMS Rehab Systems, Inc. | 106.45 USD | -19886231.611% |
| NewCardio, Inc. | - USD | -Infinity% |
| Guided Therapeutics, Inc. | 511 Thousand USD | -4042.661% |
| Ingen Technologies, Inc. | 532.27 Thousand USD | -3877.072% |
| Odyssey Group International, Inc. | - USD | -Infinity% |
| CYduct Diagnostics, Inc. | 590 Thousand USD | -3487.966% |
| Wellness Center USA, Inc. | 304.6 Thousand USD | -6849.77% |
| SANUWAVE Health, Inc. | 492 Thousand USD | -4202.642% |
| IR-Med Inc. | 161 Thousand USD | -13048.447% |
| Perimeter Medical Imaging AI, Inc. | 142.32 Thousand USD | -14773.287% |
| Polarean Imaging plc | 74.84 Thousand USD | -28183.409% |
| United American Healthcare Corporation | - USD | -Infinity% |
| ECGI Holdings, Inc. | 804 Thousand USD | -2532.96% |
| Nu-Med Plus, Inc. | - USD | -Infinity% |
| Capital Group Holdings, Inc. | - USD | -Infinity% |
| ADM Tronics Unlimited, Inc. | 322.4 Thousand USD | -6466.026% |
| Medical Supply International USA, Inc. | 116.05 Thousand USD | -18140.647% |
| Urologix, Inc. | 4.58 Million USD | -361.601% |
| Rapid Therapeutic Science Laboratories, Inc. | 430.23 Thousand USD | -4820.334% |
| Nexeon MedSystems Inc. | 2.78 Million USD | -659.745% |
| SS Innovations International, Inc. | 1.91 Million USD | -1008.074% |
| Qualis Innovations, Inc. | - USD | -Infinity% |
| Smith & Nephew plc | 2.17 Billion USD | 99.025% |
| NIOX Group Plc | 500 Thousand USD | -4133.8% |
| Fuse Medical, Inc. | 200 Thousand USD | -10484.5% |
| Broncus Holding Corporation | 1.22 Million USD | -1629.493% |
| Brain Scientific Inc. | 7378.00 USD | -286820.575% |
| Pressure BioSciences, Inc. | 161.86 Thousand USD | -12978.263% |
| Health Logic Interactive Inc. | - USD | -Infinity% |